@ivanorosas
Our team at Baylor St. Luke's #lungtransplant program in 2023 was driven to provide early access, compassionate, and world-class care for advanced lung disease patients. @BCM_Surgery @BCM_ALD ♻️🫁View quoted post on X
www.bcm.edu New drug potentially identified to expand rheumatoid arthritis-associated interstitial lung disease... The therapeutic drug pirfenidone has been found to be a potential treatment for rheumatoid arthritis-associated interstitial lung disease by researchers... 
pubmed.ncbi.nlm.nih.gov Pathogenic Mechanisms Underlying Idiopathic Pulmonary Fibrosis - PubMed The pathogenesis of idiopathic pulmonary fibrosis (IPF) involves a complex interplay of cell types and signaling pathways. Recurrent alveolar epithelial cell (AEC) injury may occur in the context of... 
www.businesswire.com Genentech Provides Update on the Phase III REMDACTA Trial of Actemra Plus Veklury in Patients With... Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the global Phase III randomized, double-blind, multicenter REMDACTA... 
